Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gilead Sciences (NASDAQ:GILD – Get Free Report) and BioCardia (NASDAQ:BCDA – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, dividends, analyst recommendations, institutional ownership and profitability. Insider and Institutional Ownership 82.3% of Gilead Sciences shares […]
Bender Robert & Associates cut its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,138 shares of the biopharmaceutical company’s stock after selling 890 shares during […]
OneAscent Wealth Management LLC purchased a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 3,852 shares of the biopharmaceutical company’s stock, valued at approximately $289,000. Several other hedge funds also recently modified […]
S.A. Mason LLC decreased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 25.4% during the 3rd quarter, Holdings Channel.com reports. The fund owned 525 shares of the biopharmaceutical company’s stock after selling 179 shares during the period. S.A. Mason LLC’s holdings in Gilead Sciences were worth $39,000 at the end […]
Register Financial Advisors LLC cut its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 13.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,350 shares of the biopharmaceutical company’s stock after selling 505 shares during the […]